Greater China

80+ Inspiring Events are Waiting for you in Hotel & Shop Plus 2024

Retrieved on: 
Wednesday, March 20, 2024
Tao, Interior, Resort, W Hotels, Sustainable development, Public, Innovation, Tourism, Exhibition, Commerce, Intelligence, Exurb, Fashion merchandising, Greater China, Convention center, Attention, International Building, IHG Hotels & Resorts, IHG, IDF, B&B, Human

SHANGHAI, March 20, 2024 /PRNewswire/ -- Hotel & Shop Plus will take place from 26-29 March 2024 in Shanghai.

Key Points: 
  • SHANGHAI, March 20, 2024 /PRNewswire/ -- Hotel & Shop Plus will take place from 26-29 March 2024 in Shanghai.
  • This event aims to be built as one-stop souring platform for the construction and operation of hotels and commercial space.
  • The 2024 IDF, with the theme of "Breakthroughs • Reinvention," will once again gather popular hotel and commercial space architects and designers in the industry.
  • Hotel & Shop Plus connects both inside and outside, developing in multiple locations.

Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer

Retrieved on: 
Monday, March 18, 2024
Novartis, NDA, Messenger, Greater China, HKEX, File, Vaccine, Amgen, Marketing, Lead, Pharmaceutical industry

SHANGHAI, March 17, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, today announced that the company has strengthened its management team with the appointments of Ms. Sandra Zeng as Chief Medical Officer and Mr. Rico Liang as Chief Product Officer.

Key Points: 
  • SHANGHAI, March 17, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, today announced that the company has strengthened its management team with the appointments of Ms. Sandra Zeng as Chief Medical Officer and Mr. Rico Liang as Chief Product Officer.
  • Ms. Sandra Zeng has been appointed Chief Medical Officer in charge of the clinical development team and cross function collaboration to bring more in-house developed and in-licensed innovative products in China.
  • Mr. Rico Liang has been appointed Chief Product Officer overseeing the Company's medical affairs and marketing departments.
  • We welcome Ms. Zeng and Mr. Liang as our new Chief Medical Officer and Chief Product Officer who bring to Everest decades of relevant global and China experience to help accelerate our strategic growth goals," said Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines.

SK Biopharmaceuticals Announces 100,000 Patients Globally Have Been Treated with Cenobamate Through Sales of XCOPRI® and ONTOZRY® in the U.S., Europe, Israel, and Canada

Retrieved on: 
Monday, March 11, 2024
Ignis, Civil service commission, Epilepsy, ASM, Ono Pharmaceutical, Partnership, Central nervous system, Patient, CNS, News, MHRA, Cenobamate, MENA, European Commission, Greater China, FDA, Swissmedic, Food, Pharmaceutical industry

GYEONGGI, Korea, and ROME, March 11, 2024 /PRNewswire/ -- SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous system (CNS) disorders and oncology, and the first and only Korean company to independently develop and commercialize a new drug in the U.S., today announced more than 100,000 patients have been treated globally with cenobamate, an anti-seizure medication (ASM) developed by SK Biopharmaceuticals and its U.S. subsidiary SK Life Science, Inc.

Key Points: 
  • In the U.S., cenobamate is marketed under the brand name XCOPRI® (cenobamate tablets) CV.
  • Since 2023, Dexcel Pharma, an international specialty pharmaceutical company, has been marketing cenobamate in Israel, and Paladin Labs Inc., launched cenobamate in Canada.
  • "This cenobamate milestone coincides with the completion earlier this year of SK Biopharmaceuticals' strategic Global Partnering plan.
  • "We are excited to continue transforming the landscape of epilepsy care with innovative treatment options and to advocate for epilepsy as a priority for healthcare systems across Europe."

The Boston Beer Company Announces CEO Succession Plan

Retrieved on: 
Tuesday, February 27, 2024
Boston Beer Company, SAM, Nike (company), Tea, Culture, Converse, Nike, Greater China, Compensated emancipation, Knowledge, Motivation, Burwick, Umbro, PepsiCo, Partnership, Management

BOSTON, MA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Boston Beer Company (NYSE: SAM) today announced leadership changes effective April 1, 2024.

Key Points: 
  • BOSTON, MA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The Boston Beer Company (NYSE: SAM) today announced leadership changes effective April 1, 2024.
  • Spillane is currently the lead director of The Boston Beer Company and has been a board member since 2016.
  • “I’ve known Dave for 19 years, and he’s had a tremendous impact on our company – first as a board member and for the last six years as our CEO,” said Boston Beer Founder and Brewer Jim Koch.
  • “His steady leadership, talent, work ethic, values, guidance, and motivation have been unwavering, and I appreciate all he did to make Boston Beer a more successful company and a better place to work.”
    During Burwick’s tenure as CEO, Boston Beer’s revenue more than doubled and its stock generated average annual returns of 12% – by far the highest among U.S. beer producers.

Delta Honored Among Clarivate's Global Top 100 Innovators for Third Consecutive Year

Retrieved on: 
Wednesday, March 6, 2024
Reward, Clarivate, Invention, Electronics, Delta Electronics, Risk, Yoy, General counsel, Information services, Patent, Ecosystem, Organization, Automation, Greater China, Intellectual property, Research

As of the end of 2023, Delta has obtained an accumulated total of 16,703 approved patents worldwide.

Key Points: 
  • As of the end of 2023, Delta has obtained an accumulated total of 16,703 approved patents worldwide.
  • Delta Electronics shows consistent innovative performance, especially in the influence and success of its inventions in the global market.
  • We congratulate Delta Electronics for being named a Top 100 Global Innovator for three consecutive years."
  • Clarivate is a leading global provider of information services and has been publishing the Top 100 Global Innovators report annually since 2012.

Manulife announces additions to its Board of Directors

Retrieved on: 
Tuesday, March 5, 2024
Market, Bank, Eastspring Investments, Prudential plc, AIG, Commerce, University, Partnership, Society of Actuaries, Espresso, Towers Perrin, Boston Consulting Group, MBA, RGA, Greater China, PhD in management, Scotiabank, Chairperson, Kanak people, Imperial College London, Saint Mary's University, Life, Chemical engineering, Master of Letters, Actuarial science, Compensated emancipation, JD, University of Oxford, Master of Science, Investment, Insurance, Corporate governance, Harvard University, Reinsurance Group of America, Senior advisor, Harvard Law School, Queen's University, Audit committee, Committee, American International Group, Management

He holds a Bachelor of Commerce from Saint Mary's University and a Ph.D. in Management from Queen's University.

Key Points: 
  • He holds a Bachelor of Commerce from Saint Mary's University and a Ph.D. in Management from Queen's University.
  • Mr. Kanak is a former senior executive with deep insurance experience in Asia.
  • He served in senior executive positions at American International Group (AIG) for over 14 years before joining Prudential.
  • "Mike, Don, Anna and John bring skills and experience critical to supporting the Board of Directors' effective oversight of Manulife given its growth ambitions and strategic priorities," said Don Lindsay, Chair of the Board, Manulife.

Reticulate Micro Names Amit Shrestha as Chief Financial Officer

Retrieved on: 
Tuesday, February 27, 2024
Online, CFO, Seattle University, Digital transformation, International finance, Public sector, PWC, Learning, Development, Culture, Reticulation, IPO, GCR, Greater China, Trust, Microsoft, Environment, Management

PALM BAY, Fla., Feb. 27, 2024 /PRNewswire/ -- Reticulate Micro, Inc. ("Reticulate Micro," "Reticulate" or the "Company"), a defense technology company dedicated to delivering trusted and resilient communications over any transport and in any environment, has appointed Amit Shrestha as Chief Financial Officer, effective March 1st.

Key Points: 
  • Veteran International Finance Leader Spent 20 Years at Microsoft, Managing Finance and Digital Transformation in Emerging and Public Sector Markets
    PALM BAY, Fla., Feb. 27, 2024 /PRNewswire/ -- Reticulate Micro, Inc. ("Reticulate Micro," "Reticulate" or the "Company"), a defense technology company dedicated to delivering trusted and resilient communications over any transport and in any environment, has appointed Amit Shrestha as Chief Financial Officer, effective March 1st.
  • In his most recent role as CFO of Microsoft Mexico, Shrestha led digital transformation efforts to help the business achieve 20% plus sustainable growth.
  • "We are thrilled to welcome Amit to the Reticulate Micro team.
  • His remarkable track record at Microsoft and profound insight promise to propel our financial strategies to new heights," said Joshua Cryer, President and CEO of Reticulate Micro.

APAC Managed and Professional Security Services Market Analysis: Growth Opportunities in Delivering Advanced Cybersecurity Services, such as IT/OT Security, XDR and SSE/SASE

Retrieved on: 
Tuesday, February 20, 2024
PSS, Internet, Security, MSS, ANZ, Organization, Greater China, Cloud computing, Research, Face

DUBLIN, Feb. 20, 2024 /PRNewswire/ -- The "Asia-Pacific (APAC) Managed and Professional Security Services Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Feb. 20, 2024 /PRNewswire/ -- The "Asia-Pacific (APAC) Managed and Professional Security Services Market" report has been added to ResearchAndMarkets.com's offering.
  • As a result, managed and professional security services (MSS and PSS) have emerged as viable services to help organizations overcome this issue.
  • This is because engaging with managed security service providers offers organizations access to a strong pool of qualified cybersecurity professionals and a wide-ranging cybersecurity service, helping them to monitor, manage, and mitigate security issues.
  • This research service provides insights into the APAC Managed and Professional Security Services market by vertical, horizontal, and region for Australia & New Zealand (ANZ), ASEAN, the Greater China Region, India, Japan, and South Korea.

Ermenegildo Zegna Group Ends Full Year 2023 on a Strong Note With Accelerated Growth in the Fourth Quarter

Retrieved on: 
Wednesday, January 31, 2024
Footwear, Fashion, Cosmetics, Retail, Luxury, Manufacturing, Textiles, Partnership, Growth, DTC, Thom Browne, FY, Acceleration, Element, Environment, Greater China, Capital market, Shoe, Marketing, Collection, Investment, Saks Fifth Avenue, Testament, TFI, CRM, Acquisition, Sale, MTM, Health, Marcolin, Webcast

Ermenegildo “Gildo” Zegna, Chairman and CEO of the Zegna Group, said: “I am very proud of the Group’s success over the past year, which is demonstrated by our strong and continued revenues growth.

Key Points: 
  • Ermenegildo “Gildo” Zegna, Chairman and CEO of the Zegna Group, said: “I am very proud of the Group’s success over the past year, which is demonstrated by our strong and continued revenues growth.
  • For the full year 2023, Zegna Group generated revenues of €1,905 million, an increase of 27.6% year-over-year.
  • In the fourth quarter of 2023, the Group generated revenues of €570 million, an increase of 40.1% year-over-year.
  • Revenues growth in the fourth quarter of 2023 accelerated from the 20.8% year-over-year growth reported in the third quarter of 2023 (on a constant currency basis, revenues growth was 25.0% in the third quarter, with an organic growth rate of 11.3% for the same period).

Aesthetic Medical International Announces Change of Auditor and Change of Director

Retrieved on: 
Tuesday, December 12, 2023
ADV, Attention, Greater China, Retirement, Bank statement, University, AIH, Barclays, Cell biology, Economics, Audit

The change of the Company’s independent registered public accounting firm was made after careful consideration and evaluation process and was approved by the audit committee and the Board.

Key Points: 
  • The change of the Company’s independent registered public accounting firm was made after careful consideration and evaluation process and was approved by the audit committee and the Board.
  • Ms. XU Tianqing was appointed as an independent director and a member of the audit committee of the Board, effective on and from December 12, 2023.
  • Prior to joining ADV, Ms. XU Tianqing worked at Barclays Capital’s investment banking division from 2018 to 2021.
  • Ms. XU Tianqing holds a dual bachelor’s degree in Molecular & Cell Biology and Economics from the University of California, Berkeley.